Overview

Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone

Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
A Randomized, Double-blinded, Double-dummy, Parallel-controlled and Multicenter Clinical trial to Investigate Blonanserin in Treatment of Schizophrenia when compared with Risperidone
Phase:
Phase 3
Details
Lead Sponsor:
Sumitomo Pharmaceutical (Suzhou) Co., Ltd.
Treatments:
Risperidone